Currently, for the acute treatment of migraine attacks, non-steroidal anti-inflammatory drugs (NSAIDs) and triptans (serotonin 5HT1B/1D receptor agonists) are recommended. Before intake of NSAID and triptans, metoclopramide or domperidone is useful. In very severe attacks, subcutaneous sumatriptan is first choice.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Acute Migraine Drugs industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Triptans
NSAIDs
Others
Market Segment by Product Application
Hospital Pharmacies
Drug Stores
Finally, the report provides detailed profile and data information analysis of leading company.
GSK
Teva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Merck
J & J
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Acute Migraine Drugs consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Acute Migraine Drugs market by identifying its various subsegments.
3.Focuses on the key global Acute Migraine Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Acute Migraine Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Acute Migraine Drugs submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Acute Migraine Drugs Market Research Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Acute Migraine Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Acute Migraine Drugs Segment by Type
2.1.1 Triptans
2.1.2 NSAIDs
2.1.3 Others
2.2 Market Analysis by Application
2.2.1 Hospital Pharmacies
2.2.2 Drug Stores
2.3 Global Acute Migraine Drugs Market Comparison by Regions (2016-2026)
2.3.1 Global Acute Migraine Drugs Market Size (2016-2026)
2.3.2 North America Acute Migraine Drugs Status and Prospect (2016-2026)
2.3.3 Europe Acute Migraine Drugs Status and Prospect (2016-2026)
2.3.4 China Acute Migraine Drugs Status and Prospect (2016-2026)
2.3.5 Japan Acute Migraine Drugs Status and Prospect (2016-2026)
2.3.6 Southeast Asia Acute Migraine Drugs Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Acute Migraine Drugs Industry Impact
2.5.1 Acute Migraine Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Acute Migraine Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Acute Migraine Drugs Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Acute Migraine Drugs Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Acute Migraine Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Acute Migraine Drugs Manufacturer Market Share
3.5 Top 10 Acute Migraine Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Acute Migraine Drugs Market
3.7 Key Manufacturers Acute Migraine Drugs Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Acute Migraine Drugs Industry Key Manufacturers
4.1 GSK
4.1.1 Compan Detail
4.1.2 GSK Acute Migraine Drugs Product Introduction, Application and Specification
4.1.3 GSK 138 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 GSK News
4.2 Teva
4.2.1 Compan Detail
4.2.2 Teva Acute Migraine Drugs Product Introduction, Application and Specification
4.2.3 Teva Acute Migraine Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 GSK News
4.3 Pfizer
4.3.1 Compan Detail
4.3.2 Pfizer Acute Migraine Drugs Product Introduction, Application and Specification
4.3.3 Pfizer Acute Migraine Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Pfizer News
4.4 Novartis
4.4.1 Compan Detail
4.4.2 Novartis Acute Migraine Drugs Product Introduction, Application and Specification
4.4.3 Novartis Acute Migraine Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Novartis News
4.5 Sun Pharma
4.5.1 Compan Detail
4.5.2 Novartis Acute Migraine Drugs Product Introduction, Application and Specification
4.5.3 Sun Pharma Acute Migraine Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Sun Pharma News
4.6 Grunenthal
4.6.1 Compan Detail
4.6.2 Grunenthal Acute Migraine Drugs Product Introduction, Application and Specification
4.6.3 Grunenthal Acute Migraine Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Grunenthal News
4.7 Endo Pharmaceuticals
4.7.1 Compan Detail
4.7.2 Endo Pharmaceuticals Acute Migraine Drugs Product Introduction, Application and Specification
4.7.3 Endo Pharmaceuticals Acute Migraine Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Merck
4.8.1 Compan Detail
4.8.2 Merck Acute Migraine Drugs Product Introduction, Application and Specification
4.8.3 Merck Acute Migraine Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Merck News
4.9 J & J
4.9.1 Compan Detail
4.9.2 J & J Acute Migraine Drugs Product Introduction, Application and Specification
4.9.3 J & J Acute Migraine Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 J & J News
5 Global Acute Migraine Drugs Market Segment by Big Type
5.1 Global Acute Migraine Drugs Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global Acute Migraine Drugs Sales and Market Share by Big Type (2016-2021)
5.1.2 Global Acute Migraine Drugs Revenue and Market Share by Big Type (2016-2021)
5.2 Triptans Sales Growth Rate and Price
5.2.1 Global Triptans Sales Growth Rate (2016-2021)
5.2.2 Global Triptans Price (2016-2021)
5.3 NSAIDs Sales Growth Rate and Price
5.3.1 Global NSAIDs Sales Growth Rate (2016-2021)
5.3.2 Global NSAIDs Price (2016-2021)
5.4 Others Sales Growth Rate and Price
5.4.1 Global Others Sales Growth Rate (2016-2021)
5.4.2 Global Others Price (2016-2021)
6 Global Acute Migraine Drugs Market Segment by Big Application
6.1 Global Acute Migraine Drugs Sales Market Share by Big Application (2016-2021)
6.2 Hospital Pharmacies Sales Growth Rate (2016-2021)
6.3 Drug Stores Sales Growth Rate (2016-2021)
7 Global Acute Migraine Drugs Forecast
7.1 Global Acute Migraine Drugs Revenue, Sales and Growth Rate (2021-2026)
7.2 Acute Migraine Drugs Market Forecast by Regions (2021-2026)
7.2.1 North America Acute Migraine Drugs Market Forecast (2021-2026)
7.2.2 Europe Acute Migraine Drugs Market Forecast (2021-2026)
7.2.3 China Acute Migraine Drugs Market Forecast (2021-2026)
7.2.4 Japan Acute Migraine Drugs Market Forecast (2021-2026)
7.2.5 Southeast Asia Acute Migraine Drugs Market Forecast (2021-2026)
7.2.6 Other Regions Acute Migraine Drugs Market Forecast (2021-2026)
7.3 Acute Migraine Drugs Market Forecast by Type (2021-2026)
7.3.1 Global Acute Migraine Drugs Sales Forecast by Type (2021-2026)
7.3.2 Global Acute Migraine Drugs Market Share Forecast by Type (2021-2026)
7.4 Acute Migraine Drugs Market Forecast by Application (2021-2026)
7.4.1 Global Acute Migraine Drugs Sales Forecast by Application (2021-2026)
7.4.2 Global Acute Migraine Drugs Market Share Forecast by Application (2021-2026)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Acute Migraine Drugs Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Acute Migraine Drugs Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Acute Migraine Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Acute Migraine Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Acute Migraine Drugs Market Size by Big Type
Figure Global Market Share of Acute Migraine Drugs by Big Type in 2020
Figure Triptans Picture (2016-2021)
Figure NSAIDs Picture (2016-2021)
Global Acute Migraine Drugs Market Size by Big Application
Table Global Acute Migraine Drugs Market Size by Application
Figure Global Acute Migraine Drugs Market Share by Big Application in 2020
Figure Hospital Pharmacies Picture
Figure Drug Stores Picture
Table Global Acute Migraine Drugs Comparison by Regions (M USD) (2016-2026)
Figure Global Acute Migraine Drugs Market Size (Million US$) (2016-2026)
Figure North America Acute Migraine Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Acute Migraine Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure China Acute Migraine Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure Japan Acute Migraine Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure Southeast Asia Acute Migraine Drugs Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Acute Migraine Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Acute Migraine Drugs Sales by Manufacturer (2016-2021)
Figure Global Acute Migraine Drugs Sales Market Share by Manufacturer in 2020
Table Global Acute Migraine Drugs Revenue by Manufacturer (2016-2021)
Figure Global Acute Migraine Drugs Revenue Market Share by Manufacturer in 2020
Table Global Acute Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Acute Migraine Drugs Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Acute Migraine Drugs Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Acute Migraine Drugs Market
Table Key Manufacturers Acute Migraine Drugs Product Type
Table Mergers & Acquisitions Planning
Table GSK Company Profile
Table Acute Migraine Drugs Product Introduction, Application and Specification of GSK
Table Acute Migraine Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021
Table Company One Main Business
Table Company One Recent Development
Table Teva Company Profile
Table Acute Migraine Drugs Product Introduction, Application and Specification of Teva
Table Acute Migraine Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Teva Recent Development
Table Pfizer Company Profile
Table Acute Migraine Drugs Product Introduction, Application and Specification of Pfizer
Table Acute Migraine Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Pfizer Main Business
Table Pfizer Recent Development
Table Novartis Company Profile
Table Acute Migraine Drugs Product Introduction, Application and Specification of Novartis
Table Acute Migraine Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Novartis Main Business
Table Novartis Recent Development
Table Novartis Main Business
Table Novartis Recent Development
Table Sun Pharma Company Profile
Table Acute Migraine Drugs Product Introduction, Application and Specification of Sun Pharma
Table Acute Migraine Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Sun Pharma Main Business
Table Sun Pharma Recent Development
Table Grunenthal Company Profile
Table Acute Migraine Drugs Product Introduction, Application and Specification of Grunenthal
Table Acute Migraine Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Grunenthal Main Business
Table Grunenthal Recent Development
Table Endo Pharmaceuticals Company Profile
Table Acute Migraine Drugs Product Introduction, Application and Specification of Endo Pharmaceuticals
Table Acute Migraine Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Endo Pharmaceuticals Main Business
Table Endo Pharmaceuticals Recent Development
Table Merck Company Profile
Table Acute Migraine Drugs Product Introduction, Application and Specification of Merck
Table Acute Migraine Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Merck Main Business
Table Merck Recent Development
Table J & J Company Profile
Table Acute Migraine Drugs Product Introduction, Application and Specification of J & J
Table Acute Migraine Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table J & J Main Business
Table J & J Recent Development
Figure Global Acute Migraine Drugs Sales and Growth Rate (2016-2021)
Figure Global Acute Migraine Drugs Revenue and Growth Rate (2016-2021)
Table Global Acute Migraine Drugs Sales by Regions (2016-2021)
Figure Global Acute Migraine Drugs Sales Market Share by Regions in 2020
Table Global Acute Migraine Drugs Revenue by Regions (2016-2021)
Figure Global Acute Migraine Drugs Revenue Market Share by Regions in 2020
Figure North America Acute Migraine Drugs Sales and Growth Rate (2016-2021)
Figure Europe Acute Migraine Drugs Sales and Growth Rate (2016-2021)
Figure China Acute Migraine Drugs Sales and Growth Rate (2016-2021)
Figure Japan Acute Migraine Drugs Sales and Growth Rate (2016-2021)
Figure Southeast Asia Acute Migraine Drugs Sales and Growth Rate (2016-2021)
Figure Other Regions Acute Migraine Drugs Sales and Growth Rate (2016-2021)
Table Global Acute Migraine Drugs Sales by Big Type (2016-2021)
Table Global Acute Migraine Drugs Sales Market Share by Big Type (2016-2021)
Figure Global Acute Migraine Drugs Sales Market Share by Big Type in 2019
Table Global Acute Migraine Drugs Revenue by Big Type (2016-2021)
Table Global Acute Migraine Drugs Revenue Market Share by Big Type (2016-2021)
Table Global Acute Migraine Drugs Revenue Market Share by Big Type in 2019
Figure Global Triptans Sales Growth Rate (2016-2021)
Figure Global Triptans Price (2016-2021)
Figure Global NSAIDs Sales Growth Rate (2016-2021)
Figure Global NSAIDs Price (2016-2021)
Figure Global Others Sales Growth Rate (2016-2021)
Table Global Acute Migraine Drugs Sales by Big Application (2016-2021)
Table Global Acute Migraine Drugs Sales Market Share by Big Application (2016-2021)
Figure Global Acute Migraine Drugs Sales Market Share by Big Application in 2019
Figure Global Hospital Pharmacies Sales Growth Rate (2016-2021)
Figure Global Drug Stores Sales Growth Rate (2016-2021)
Figure Global Acute Migraine Drugs Sales and Growth Rate (2021-2026)
Figure Global Acute Migraine Drugs Revenue and Growth Rate (2021-2026)
Table Global Acute Migraine Drugs Sales Forecast by Regions (2021-2026)
Table Global Acute Migraine Drugs Market Share Forecast by Regions (2021-2026)
Figure North America Sales Acute Migraine Drugs Market Forecast (2021-2026)
Figure Europe Sales Acute Migraine Drugs Market Forecast (2021-2026)
Figure China Sales Acute Migraine Drugs Market Forecast (2021-2026)
Figure Japan Sales Acute Migraine Drugs Market Forecast (2021-2026)
Figure Southeast Asia Sales Acute Migraine Drugs Market Forecast (2021-2026)
Figure Other Regions Sales Acute Migraine Drugs Market Forecast (2021-2026)
Table Global Acute Migraine Drugs Sales Forecast by Type (2021-2026)
Table Global Acute Migraine Drugs Market Share Forecast by Type (2021-2026)
Table Global Acute Migraine Drugs Sales Forecast by Application (2021-2026)
Table Global Acute Migraine Drugs Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Acute Migraine Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Acute Migraine Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Acute Migraine Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Acute Migraine Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Acute Migraine Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Acute Migraine Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Acute Migraine Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Acute Migraine Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Acute Migraine Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
GSK
Teva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals